Marco Marcarelli1, Marcello Zappia2, Lorenzo Rissolio1, Chiara Baroni1, Carlo Astarita3,4, Letizia Trovato4, Antonio Graziano3,4. 1. Unit of Orthopedics and Traumatology of Chieri and Moncalieri, Santa Croce Hospital, 10024 Turin, Italy. 2. Department of Medicine and Health Sciences, University of Molise, 86100 Campobasso, Italy. 3. Human Brain Wave, Corso Galileo Ferraris, 63, 10128 Turin, Italy. 4. Sbarro Institute for Cancer Research and Molecular Medicine, Department of Biology, College of Science and Technology, Temple University, Philadelphia, PA 19126, USA.
Abstract
(1) Background: Focal chondral defects of the knee can significantly impair patient quality of life. Although different options are available, they are still not conclusive and have several limitations. The aim of this study was to evaluate the role of autologous cartilage micrografts in the treatment of knee chondropathy. (2) Methods: Eight patients affected by knee chondropathy were evaluated before and after 6 months and 3 years following autologous cartilage micrografts by magnetic resonance imaging (MRI) for cartilage measurement and clinical assessment. (3) Results: All patients recovered daily activities, reporting pain reduction without the need for analgesic therapy; Oxford Knee Score (OKS) was 28.4 ± 6 and 40.8 ± 6.2 and visual analogue scale (VAS) was 5.5 ± 1.6 and 1.8 ± 0.7 before and after 6 months following treatment, respectively. Both scores remained stable after 3 years. Lastly, a significant improvement of the cartilage thickness was observed using MRI after 3 years. (4) Conclusions: Autologous cartilage micrografts can promote the formation of new cartilage, and could be a valid approach for the treatment of knee chondropathy.
(1) Background: Focal chondral defects of the knee can significantly impair patient quality of life. Although different options are available, they are still not conclusive and have several limitations. The aim of this study was to evaluate the role of autologous cartilage micrografts in the treatment of knee chondropathy. (2) Methods: Eight patients affected by knee chondropathy were evaluated before and after 6 months and 3 years following autologous cartilage micrografts by magnetic resonance imaging (MRI) for cartilage measurement and clinical assessment. (3) Results: All patients recovered daily activities, reporting pain reduction without the need for analgesic therapy; Oxford Knee Score (OKS) was 28.4 ± 6 and 40.8 ± 6.2 and visual analogue scale (VAS) was 5.5 ± 1.6 and 1.8 ± 0.7 before and after 6 months following treatment, respectively. Both scores remained stable after 3 years. Lastly, a significant improvement of the cartilage thickness was observed using MRI after 3 years. (4) Conclusions: Autologous cartilage micrografts can promote the formation of new cartilage, and could be a valid approach for the treatment of knee chondropathy.
Entities:
Keywords:
cartilage micrografts; medical device; regenerative medicine
Authors: Fabiano Svolacchia; Francesco De Francesco; Letizia Trovato; Antonio Graziano; Giuseppe A Ferraro Journal: J Cosmet Dermatol Date: 2016-01-30 Impact factor: 2.696
Authors: Francesco De Francesco; Antonio Graziano; Letizia Trovato; Gabriele Ceccarelli; Maurizio Romano; Marco Marcarelli; Gabriella Maria Cusella De Angelis; Umberto Cillo; Michele Riccio; Giuseppe Andrea Ferraro Journal: Stem Cell Rev Rep Date: 2017-02 Impact factor: 5.739
Authors: Marco Viganò; Irene Tessaro; Letizia Trovato; Alessandra Colombini; Marco Scala; Alberto Magi; Andrea Toto; Giuseppe Peretti; Laura de Girolamo Journal: J Orthop Surg Res Date: 2018-11-06 Impact factor: 2.359
Authors: Michele Riccio; Andrea Marchesini; Nicola Zingaretti; Sara Carella; Letizia Senesi; Maria Giuseppina Onesti; Pier Camillo Parodi; Diego Ribuffo; Luca Vaienti; Francesco De Francesco Journal: Stem Cells Int Date: 2019-12-01 Impact factor: 5.443